Literature DB >> 31432321

muw researcher of the month.

.   

Abstract

Year:  2019        PMID： 31432321     DOI： 10.1007/s00508-019-01538-3

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  6 in total

Review 1.  RNA editing by adenosine deaminases that act on RNA.

Authors:  Brenda L Bass
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

2.  Rudhira/BCAS3 is a cytoskeletal protein that controls Cdc42 activation and directional cell migration during angiogenesis.

Authors:  Mamta Jain; Ganesh P Bhat; K Vijayraghavan; Maneesha S Inamdar
Journal:  Exp Cell Res       Date:  2012-01-25       Impact factor: 3.905

Review 3.  A-to-I editing of coding and non-coding RNAs by ADARs.

Authors:  Kazuko Nishikura
Journal:  Nat Rev Mol Cell Biol       Date:  2015-12-09       Impact factor: 94.444

Review 4.  Adenosine-to-Inosine RNA Editing in Health and Disease.

Authors:  Aikaterini Gatsiou; Nikolaos Vlachogiannis; Federica Francesca Lunella; Marco Sachse; Konstantinos Stellos
Journal:  Antioxid Redox Signal       Date:  2017-09-26       Impact factor: 8.401

5.  Rudhira/BCAS3 is essential for mouse development and cardiovascular patterning.

Authors:  Ronak Shetty; Divyesh Joshi; Mamta Jain; Madavan Vasudevan; Jasper Chrysolite Paul; Ganesh Bhat; Poulomi Banerjee; Takaya Abe; Hiroshi Kiyonari; K VijayRaghavan; Maneesha S Inamdar
Journal:  Sci Rep       Date:  2018-04-04       Impact factor: 4.379

6.  RNA editing of Filamin A pre-mRNA regulates vascular contraction and diastolic blood pressure.

Authors:  Mamta Jain; Tomer D Mann; Maja Stulić; Shailaja P Rao; Andrijana Kirsch; Dieter Pullirsch; Xué Strobl; Claus Rath; Lukas Reissig; Kristin Moreth; Tanja Klein-Rodewald; Raffi Bekeredjian; Valerie Gailus-Durner; Helmut Fuchs; Martin Hrabě de Angelis; Eleonore Pablik; Laura Cimatti; David Martin; Jelena Zinnanti; Wolfgang F Graier; Maria Sibilia; Saša Frank; Erez Y Levanon; Michael F Jantsch
Journal:  EMBO J       Date:  2018-08-07       Impact factor: 11.598
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.